. Author manuscript; available in PMC: 2016 Sep 1.

Published in final edited form as: J Clin Psychol Med Settings. 2015 Sep;22(0):150–159. doi: 10.1007/s10880-015-9427-6

Table 2.

Participant demographics and medication information

	Total group	TRS group	Control group	p value	Univariate analyses
Mean age at transfer (in years)	20.49 (1.13)	20.86 (.83)	19.99 (1.31)	.024^*	Z = –2.264
Mean age at transfer (in years)	N = 45	n = 26	n = 19		U = 148.5
Mean time since transplant at transfer (in years)	12.00 (6.46)	13.47 (6.51)	9.99 (5.97)	.085	Z = 1.724
Mean time since transplant at transfer (in years)	N = 45	n = 26	n = 19		U = 172.00
Number of pre-transfer BPR (% of participants with 1 or more BPR)	5 (6.6 %)	1 (3.8 %)	4 (10.6 %)	.366	Z = –.903
	N = 45	n = 26	n = 19		U = 230.00
Number of post-transfer BPR (% of participants with 1 or more BPR)	3 (4.6 %)	0 (0 %)	3 (10.6 %)	.101	Z = –1.641
	N = 44	n = 25	n = 19		U = 212.50
Number of deaths post transfer	2	1	1	.822	Z = –.225
Number of deaths post transfer	N = 45	n = 26	n = 18		U = 243.50
Number of participants with pre-transfer graft loss	0	0	0	–	–
Number of participants with pre-transfer graft loss	N = 45	n = 26	n = 19
Number of participants with post-transfer graft loss	2	1	1	.844	Z = –.197
Number of participants with post-transfer graft loss	N = 44	n = 25	n = 18		U = 234.50
Number of undetectable IST values pre	12	8	4	.08	Z = –1.75
Number of undetectable IST values pre	N = 44	n = 25	n = 19		U = 179.00
Number of undetectable IST values post	11	4	7	.245	Z = –.798
Number of undetectable IST values post	N = 44	n = 26	n = 18		U = 211.5

BPR biopsy-proven rejection, IST immunosuppressant therapy

p < 0.05